Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase III Study of PA21 in Peritoneal Dialysis Patients With Hyperphosphatemia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01852682
Recruitment Status : Completed
First Posted : May 14, 2013
Last Update Posted : November 13, 2014
Sponsor:
Information provided by (Responsible Party):
Kissei Pharmaceutical Co., Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 2014
Study Completion Date : No date given